Cetera Advisors’s NeoGenomics NEO Stock Holding History

Cetera Advisors’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,316	Closed	-$208K	–	1500
2021 Q3	$208K	Buy	+4,316	New	+$200K	﹤0.01%	1284

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cetera Advisors's NEO Position: Q4 2021 in Review

Cetera Advisors sold out of NeoGenomics (NEO) in Q4 2021, closing a stake of 4,316 shares — an estimated $208K sold.

Cetera Advisors first reported a position in NEO in Q3 2021 and held it in 1 quarter. The position peaked at $208K in Q3 2021. 307 funds tracked by Wall St. Rank hold NEO as of Q4 2021.

Cetera Advisors reported no remaining NeoGenomics position as of Q4 2021 after selling out during the quarter.
Cetera Advisors sold 4,316 NeoGenomics shares in Q4 2021, an estimated $208K.
Cetera Advisors first reported a position in NeoGenomics in Q3 2021 and held it in 1 quarter.
Cetera Advisors's NeoGenomics position peaked at $208K in Q3 2021.
307 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.

Based on Cetera Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.